HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by First Horizon Advisors Inc.

First Horizon Advisors Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.4% in the 3rd quarter, Holdings Channel.com reports. The firm owned 1,532 shares of the company’s stock after acquiring an additional 36 shares during the quarter. First Horizon Advisors Inc.’s holdings in HCA Healthcare were worth $623,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in HCA. Bangor Savings Bank increased its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter worth approximately $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the second quarter valued at about $28,000. GPS Wealth Strategies Group LLC grew its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $332.22 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $84.15 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. The firm’s 50 day simple moving average is $380.80 and its 200-day simple moving average is $357.94. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Analyst Upgrades and Downgrades

HCA has been the topic of several research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Royal Bank of Canada raised their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Finally, Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

Check Out Our Latest Stock Report on HCA

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.